UCB Pharma S.A. v. Nektar Therapeutics
1:20-cv-00650
Overview
Parties
Defendant
Nektar Therapeutics NPE (Individual / Inventor)
Represented By
6 Attorneys ListedRichards, Layton & Finger, PA
Richards, Layton & Finger, PA, One Rodney Square
Plaintiff
Celltech R&D Limited NPE (University / Research)
Represented By
3 Attorneys ListedMorris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Morris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Morris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
UCB Pharma S.A. NPE (Individual / Inventor)
Represented By
8 Attorneys ListedMorris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Morris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Morris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Court & Judges
Court
District Court, D. Delaware (ded)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360° Radar 10 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| 🇺🇸 United States | US 7,767,784 B2 Asserted | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 8,193,306 B2 | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 8,461,295 B2 | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 8,809,489 B2 | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 9,334,364 B2 | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 9,732,189 B2 | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 10,421,838 B2 | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 2019037589 | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 2021013054 | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 70,370,905 P | US Continuation / Sibling | View Official Patent → |
No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.
Patents Involved
There are 4 patents involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US7767784
Methods for preparing polymeric reagents and compositions of polymeric reagents
|
Filed: 2006-07-31
Issued: 2010-08-03
|
Active (2.4 yrs remaining)
+973d PTA
Expires: 2029-03-30
|
|
|
US8193306
Methods for preparing polymeric reagents and compositions of polymeric reagents
|
Filed: 2010-06-21
Issued: 2012-06-05
|
Expired (Term Ended)
Expires: 2026-09-09
|
|
|
US8461295
Methods for preparing polymeric reagents and compositions of polymeric reagents
|
Filed: 2012-05-03
Issued: 2013-06-11
|
Active (5.5 yrs remaining)
Expires: 2032-05-03
|
|
|
US8809489
Methods for preparing polymeric reagents and compositions of polymeric reagents
|
Filed: 2013-05-15
Issued: 2014-08-19
|
Active (6.5 yrs remaining)
Expires: 2033-05-15
|
Patent Enforceability & Injunction Risk Assessment
Active Threat — Patent is within enforceable statutory term. Patentee retains legal standing to seek permanent injunctive relief and exclusion orders.
High PTA (+973 days) / Cellect Scrutiny — Over 973 days of PTA awarded. Susceptible to In re Cellect double patenting invalidation if continuation patents in the same family expire earlier.
Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).
Procedural Motions & Interlocutory Orders
Total Motions
35
Dispositive
0
Granted
0
Denied
0
Pending / Review
24
Motions by Category
Key Dispositive Motions & Rulings